Real-World Effectiveness of Direct-Acting Antiviral Regimens against Hepatitis C Virus (HCV) Genotype 3 Infection: A Systematic Review and Meta-Analysis Liwei Zhuang; Junnan Li; Yu Zhang; Shibo Ji; Yue Li; Yingying Zhao; Ben Li; Wei Li; Min Quan; Ying Duan; Hong Zhao; Danying Cheng; Xiaomei Wang; Weini Ou; Huichun Xing;

The impact of direct-acting antivirals on quality of life in patients with hepatitis C virus infection: A meta-analysis Na He; Gong Feng; Shuai Hao; Meiqi Xu; Jing Liu; Fanjiao Kong; Zhuoxu Ren; Wenli Dou; Chengzi Yao; Tian Liang; Juan Wang;

Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico JC Jiménez-Mendoza; FE Rivera-López; MF González-Lara; RD Valdez-Echeverría; GE Castro-Narro; A Tore; LF Uscanga-Domínguez; C Moctezuma-Velázquez;